UBS Group’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.56M | Sell |
154,804
-102,636
| -40% | -$1.69M | ﹤0.01% | 4881 |
|
|
2026
Q1 | $4.19M | Buy |
257,440
+68,647
| +36% | +$1.07M | ﹤0.01% | 4251 |
|
|
2025
Q4 | $2.8M | Sell |
188,793
-141,772
| -43% | -$2M | ﹤0.01% | 4640 |
|
|
2025
Q3 | $4.24M | Buy |
330,565
+47,314
| +17% | +$631K | ﹤0.01% | 4215 |
|
|
2025
Q2 | $4.3M | Buy |
283,251
+57,833
| +26% | +$902K | ﹤0.01% | 4033 |
|
|
2025
Q1 | $3.76M | Sell |
225,418
-238,489
| -51% | -$4.39M | ﹤0.01% | 4069 |
|
|
2024
Q4 | $8.74M | Buy |
463,907
+291,551
| +169% | +$5.62M | ﹤0.01% | 3212 |
|
|
2024
Q3 | $3.24M | Buy |
172,356
+110,067
| +177% | +$2.11M | ﹤0.01% | 3513 |
|
|
2024
Q2 | $1.18M | Sell |
62,289
-106,652
| -63% | -$1.82M | ﹤0.01% | 4261 |
|
|
2024
Q1 | $2.74M | Sell |
168,941
-26,318
| -13% | -$385K | ﹤0.01% | 3620 |
|
|
2023
Q4 | $2.47M | Buy |
195,259
+124,106
| +174% | +$1.57M | ﹤0.01% | 3577 |
|
|
2023
Q3 | $969K | Sell |
71,153
-81,787
| -53% | -$1.26M | ﹤0.01% | 4098 |
|
|
2023
Q2 | $2.63M | Buy |
152,940
+68,182
| +80% | +$1.06M | ﹤0.01% | 3261 |
|
|
2023
Q1 | $1.18M | Buy |
84,758
+81,556
| +2,547% | +$1.2M | ﹤0.01% | 3966 |
|
|
2022
Q4 | $42.8K | Sell |
3,202
-649
| -17% | -$8.39K | ﹤0.01% | 6914 |
|
|
2022
Q3 | $46K | Sell |
3,851
-932
| -19% | -$13.2K | ﹤0.01% | 6433 |
|
|
2022
Q2 | $61K | Sell |
4,783
-495
| -9% | -$6.35K | ﹤0.01% | 5769 |
|
|
2022
Q1 | $69K | Buy |
5,278
+3,780
| +252% | +$49.9K | ﹤0.01% | 6185 |
|
|
2021
Q4 | $24K | Sell |
1,498
-15,805
| -91% | -$270K | ﹤0.01% | 7640 |
|
|
2021
Q3 | $337K | Sell |
17,303
-591
| -3% | -$11.7K | ﹤0.01% | 4974 |
|
|
2021
Q2 | $407K | Buy |
17,894
+10,080
| +129% | +$209K | ﹤0.01% | 4881 |
|
|
2021
Q1 | $144K | Sell |
7,814
-12,975
| -62% | -$213K | ﹤0.01% | 5689 |
|
|
2020
Q4 | $310K | Buy |
20,789
+18,772
| +931% | +$245K | ﹤0.01% | 4944 |
|
|
2020
Q3 | $23K | Buy |
2,017
+1,527
| +312% | +$15K | ﹤0.01% | 6208 |
|
|
2020
Q2 | $4K | Sell |
490
-14,013
| -97% | -$116K | ﹤0.01% | 7470 |
|
|
2020
Q1 | $117K | Buy |
14,503
+10,748
| +286% | +$128K | ﹤0.01% | 5154 |
|
|
2019
Q4 | $47K | Sell |
3,755
-122,408
| -97% | -$1.32M | ﹤0.01% | 6383 |
|
|
2019
Q3 | $1.13M | Buy |
126,163
+119,502
| +1,794% | +$1.04M | ﹤0.01% | 3864 |
|
|
2019
Q2 | $57K | Buy |
6,661
+6,162
| +1,235% | +$48.7K | ﹤0.01% | 5804 |
|
|
2019
Q1 | $4K | Sell |
499
-72,201
| -99% | -$580K | ﹤0.01% | 7270 |
|
|
2018
Q4 | $601K | Sell |
72,700
-33,459
| -32% | -$320K | ﹤0.01% | 4129 |
|
|
2018
Q3 | $1.05M | Buy |
106,159
+77,408
| +269% | +$801K | ﹤0.01% | 3802 |
|
|
2018
Q2 | $281K | Buy |
28,751
+14,389
| +100% | +$141K | ﹤0.01% | 4727 |
|
|
2018
Q1 | $133K | Buy |
14,362
+13,735
| +2,191% | +$131K | ﹤0.01% | 5042 |
|
|
2017
Q4 | $6K | Sell |
627
-1,487
| -70% | -$14.2K | ﹤0.01% | 7316 |
|
|
2017
Q3 | $22K | Sell |
2,114
-2,233
| -51% | -$20.6K | ﹤0.01% | 6380 |
|
|
2017
Q2 | $36K | Buy |
4,347
+4,160
| +2,225% | +$31.2K | ﹤0.01% | 5885 |
|
|
2017
Q1 | $1K | Sell |
187
-2,829
| -94% | -$20.5K | ﹤0.01% | 7456 |
|
|
2016
Q4 | $21K | Sell |
3,016
-3,285
| -52% | -$22.9K | ﹤0.01% | 6487 |
|
|
2016
Q3 | $46K | Buy |
6,301
+2,260
| +56% | +$14.4K | ﹤0.01% | 5590 |
|
|
2016
Q2 | $24K | Sell |
4,041
-1,067
| -21% | -$7.07K | ﹤0.01% | 6153 |
|
|
2016
Q1 | $33K | Sell |
5,108
-772
| -13% | -$4.14K | ﹤0.01% | 5815 |
|
|
2015
Q4 | $38K | Buy |
5,880
+763
| +15% | +$4.77K | ﹤0.01% | 6088 |
|
|
2015
Q3 | $30K | Sell |
5,117
-3,255
| -39% | -$24.1K | ﹤0.01% | 6291 |
|
|
2015
Q2 | $73K | Buy |
8,372
+2,646
| +46% | +$22.2K | ﹤0.01% | 5664 |
|
|
2015
Q1 | $46K | Sell |
5,726
-354,798
| -98% | -$2.65M | ﹤0.01% | 6132 |
|
|
2014
Q4 | $2.8M | Buy |
+360,524
| New | +$2.63M | ﹤0.01% | 2587 |
|
Other funds holding SEM
GCL
AA
DAM
PAMP
UBS Group's SEM Position: Q2 2026 in Review
UBS Group reduced its Select Medical (SEM) stake by 40% in Q2 2026, selling an estimated $1.69M and leaving 154,804 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #4881.
UBS Group first reported a position in SEM in Q4 2014 and has held it in 47 quarters since. The position peaked at $8.74M in Q4 2024. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.
- UBS Group held 154,804 shares of Select Medical worth $2.56M as of Q2 2026.
- UBS Group sold 102,636 Select Medical shares in Q2 2026, an estimated $1.69M.
- Select Medical made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4881 holding.
- UBS Group first reported a position in Select Medical in Q4 2014 and has held it in 47 quarters since.
- UBS Group's Select Medical position peaked at $8.74M in Q4 2024.
- 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.